Cargando…

Pharmacological correction of a defect in PPARγ signaling ameliorates disease severity in Cftr-deficient mice

Detalles Bibliográficos
Autores principales:	Harmon, Gregory S., Dumlao, Darren S., Ng, Damian T., Barrett, Kim E., Dennis, Edward A., Dong, Hui, Glass, Christopher K.
Formato:	Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834836/ https://www.ncbi.nlm.nih.gov/pubmed/20154695 http://dx.doi.org/10.1038/nm.2101

Ejemplares similares

Pharmacological Repression of PPARγ Promotes Osteogenesis
por: Marciano, David P., et al.
Publicado: (2015)

MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice
por: Wang, Xu, et al.
Publicado: (2017)

Dietary component isorhamnetin is a PPARγ antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency
por: Zhang, Yu, et al.
Publicado: (2016)

Pharmacological Responses of the G542X-CFTR to CFTR Modulators
por: Fang, Xinxiu, et al.
Publicado: (2022)

Correction: Assessing Phospholipase A(2) Activity toward Cardiolipin by Mass Spectrometry
por: Hsu, Yuan-Hao, et al.
Publicado: (2013)

PPARα-mediated peroxisome induction compensates PPARγ-deficiency in bronchiolar club cells
por: Karnati, Srikanth, et al.
Publicado: (2018)

Geniposide ameliorated sepsis-induced acute kidney injury by activating PPARγ
por: Liu, Jinhong, et al.
Publicado: (2020)

Loss of Hepatocyte-Specific PPARγ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet
por: Cordoba-Chacon, Jose
Publicado: (2020)

Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012)

PPARγ deficiency results in reduced lung elastic recoil and abnormalities in airspace distribution
por: Simon, Dawn M, et al.
Publicado: (2010)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Warm Reception? Halogenated BPA Flame Retardants and PPARγ Activation
por: Barrett, Julia R.
Publicado: (2011)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

PPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
por: Han, Jee-Young, et al.
Publicado: (2010)

Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach
por: Zanardelli, Matteo, et al.
Publicado: (2014)

Author Correction: CFTR function, pathology and pharmacology at single-molecule resolution
por: Levring, Jesper, et al.
Publicado: (2023)

Lipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice
por: O’Donnell, Peter E., et al.
Publicado: (2016)

Peroxisome Proliferator Activator Receptor (PPAR)-γ Ligand, but Not PPAR-α, Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver
por: El-Sheikh, Azza A. K., et al.
Publicado: (2014)

Therapeutic Implications of PPARγ in Human Osteosarcoma
por: Wagner, Eric R., et al.
Publicado: (2010)

Assessing Phospholipase A(2) Activity toward Cardiolipin by Mass Spectrometry
por: Hsu, Yuan-Hao, et al.
Publicado: (2013)

Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation
por: Park, Chung-Hwa, et al.
Publicado: (2017)

Abscisic acid interplays with PPARγ receptors and ameliorates diabetes-induced cognitive deficits in rats
por: Kooshki, Razieh, et al.
Publicado: (2021)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool
por: Quintão, Nara Lins Meira, et al.
Publicado: (2019)

Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPARγ by inverse agonists
por: Irwin, Sean, et al.
Publicado: (2022)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway
por: Zhang, Mu, et al.
Publicado: (2018)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

SAT-152 Loss of Hepatocyte PPARγ Expression Ameliorates Steatosis in Mice Fed a High-Fat, Cholesterol, and Fructose Diet, but Not in Mice Fed a Methionine- and Choline-Deficient Diet
por: Tummala, Apoorva, et al.
Publicado: (2019)

Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators
por: Estabrooks, Samuel, et al.
Publicado: (2020)

CFTR function, pathology and pharmacology at single-molecule resolution
por: Levring, Jesper, et al.
Publicado: (2023)

αCGRP deficiency aggravates pulmonary fibrosis by activating the PPARγ signaling pathway
por: Lv, Xiaoting, et al.
Publicado: (2023)

Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene
por: Venturini, Arianna, et al.
Publicado: (2021)

Acetylation-defective mutants of Pparγ are associated with decreased lipid synthesis in breast cancer cells
por: Tian, Lifeng, et al.
Publicado: (2014)

Helicobacter pylori Colonization Ameliorates Glucose Homeostasis in Mice through a PPAR γ-Dependent Mechanism
por: Bassaganya-Riera, Josep, et al.
Publicado: (2012)

Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis
por: Yu, Jung Hwan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pr0qervbrvb29grtm9of80d7qf